Levodopa-carbidopa intestinal gel is an option in Parkinson's disease with hyponatremia induced by dopamine agonists.

Neurol Sci

Center for Neurodegenerative diseases (CEMAND), Department of Medicine, Surgery and Dentistry, Neuroscience section, University of Salerno, Via Allende, 84084, Baronissi, SA, Italy.

Published: November 2020

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10072-020-04501-7DOI Listing

Publication Analysis

Top Keywords

levodopa-carbidopa intestinal
4
intestinal gel
4
gel option
4
option parkinson's
4
parkinson's disease
4
disease hyponatremia
4
hyponatremia induced
4
induced dopamine
4
dopamine agonists
4
levodopa-carbidopa
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!